In October of 1982, Tylenol, the leading painkiller medicine in the United States at the time, faced a tremendous crisis when seven people in Chicago were reported dead after taking extra-strength Tylenol capsules. It was reported that an unknown suspect/s put 65 milligrams of deadly cyanide into Tylenol capsules, 10,000 more than what is necessary to kill a human.
The tampering occurred once the product reached the shelves. They were removed from the shelves, infected with cyanide and returned to the shelves (A. Center, P. Jackson, 2003). In 1982, Tylenol controlled 37 percent of its market with revenue of about $1.2 million. Immediately after the cyanide poisonings, its market share was reduced to seven percent (A.Center, P. Jackson, 2003).
Once the connection was made between the Tylenol capsules and the reported deaths, public announcements were made warning people about the consumption of the product. Johnson & Johnson were faced with the dilemma of the best way to deal with the problem without destroying the reputation of the company and its most profitable product.
Following one of our guidelines of protecting people first and property second, McNeil Consumer Products, a subsidiary of Johnson & Johnson, conducted an immediate product recall from the entire country, which amounted to about 31 million bottles and a loss of more than $100 million dollars. Additionally, they halted all advertisement for the product.
Although Johnson & Johnson knew they were not responsible for the tampering of the product, they assumed responsibility by ensuring public safety first and recalled all of their capsules from the market. In fact, in February of 1986, when a woman was reported dead from cyanide poisoning in Tylenol capsules, Johnson & Johnson permanently removed all of the capsules from the market.
The reason Tylenol reacted so quickly and in such a positive...